Development, Validation and Field Evaluation of the Singapore Longitudinal Ageing Study (SLAS) Risk Index for Prediction of Mild Cognitive Impairment and Dementia - 21/11/24

Doi : 10.14283/jpad.2021.19 
Tze Pin Ng 1, 2, , T.S. Lee 3, W.S. Lim 4, M.S. Chong 2, P. Yap 5, C.Y. Cheong 5, K.B. Yap 6, I. Rawtaer 7, T.M. Liew 8, Q. Gao 1, X. Gwee 1, M.P.E. Ng 2, S.O. Nicholas 2, S.L. Wee 2, 9
1 Gerontological Research Programme, Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Level 9, NUHS Tower Block, 1E Kent Ridge Road, 119228, Singapore, Singapore 
2 Geriatric Education and Research Institute, Singapore, Singapore 
3 Duke-NUS Medical School, Singapore, Singapore 
4 Department of Geriatric Medicine, Tan Tock Seng Hospital, Singapore, Singapore 
5 Department of Geriatric Medicine, Khoo Teck Puat Hospital, Singapore, Singapore 
6 Department of Geriatric Medicine, Ng Teng Fong General Hospital, Singapore, Singapore 
7 Department of Psychiatry, Sengkang General Hospital, Singapore, Singapore 
8 Department of Psychiatry, Singapore General Hospital, Singapore, Singapore 
9 Health and Social Sciences Cluster, Singapore Institute of Technology, Singapore, Singapore 

a pcmngtp@nus.edu.sg pcmngtp@nus.edu.sg

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Abstract

Background

Mild cognitive impairment (MCI) is a critical pre-dementia target for preventive interventions. There are few brief screening tools based on self-reported personal lifestyle and health-related information for predicting MCI that have been validated for their generalizability and utility in primary care and community settings.

Objective

To develop and validate a MCI risk prediction index, and evaluate its field application in a pilot community intervention trial project.

Design

Two independent population-based cohorts in the Singapore Longitudinal Ageing Study (SLAS). We used SLAS1 as a development cohort to construct the risk assessment instrument, and SLA2 as a validation cohort to verify its generalizability.

Setting

Community-based screening and lifestyle intervention Participants: (1) SLAS1 cognitively normal (CN) aged ≥55 years with average 3 years (N=1601); (2) SLAS2 cohort (N=3051) with average 4 years of follow up. (3) 437 participants in a pilot community intervention project.

Measurements

The risk index indicators included age, female sex, years of schooling, hearing loss, depression, life satisfaction, number of cardio-metabolic risk factors (wide waist circumference, pre-diabetes or diabetes, hypertension, dyslipidemia). Weighted summed scores predicted probabilities of MCI or dementia. A self-administered questionnaire field version of the risk index was deployed in the pilot community project and evaluated using pre-intervention baseline cognitive function of participants.

Results

Risk scores were associated with increasing probabilities of progression to MCI-or-dementia in the development cohort (AUC=0.73) and with increased prevalence and incidence of MCI-or-dementia in the validation cohort (AUC=0.74). The field questionnaire risk index identified high risk individuals with strong correlation with RBANS cognitive scores in the community program (p<0.001).

Conclusions

The SLAS risk index is accurate and replicable in predicting MCI, and is applicable in community interventions for dementia prevention.

Il testo completo di questo articolo è disponibile in PDF.

Key words : Mild cognitive impairment, dementia, metabolic syndrome, diabetes, cardiovascular risk factors


Mappa


© 2021  THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 8 - N° 3

P. 335-344 - Marzo 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Elevated Blood Homocysteine and Risk of Alzheimer’s Dementia: An Updated Systematic Review and Meta-Analysis Based on Prospective Studies
  • M. Zuin, Carlo Cervellati, G. Brombo, A. Trentini, L. Roncon, G. Zuliani
| Articolo seguente Articolo seguente
  • Childhood Secondhand Smoke Exposure and Risk of Dementia, Alzheimer’s Disease and Stroke in Adulthood: A Prospective Cohort Study
  • S. Zhou, Kanran Wang

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.